Connection

Dingyu Zhang to China

Back to Details
This is a "connection" page, showing publications Dingyu Zhang has written about China.
Dingyu Zhang
Connection Strength
0.119
China
  1. The predicting roles of carcinoembryonic antigen and its underlying mechanism in the progression of coronavirus disease 2019. Crit Care. 2021 07 03; 25(1):234.
    View in: PubMed
    Score: 0.008
  2. A cohort autopsy study defines COVID-19 systemic pathogenesis. Cell Res. 2021 08; 31(8):836-846.
    View in: PubMed
    Score: 0.008
  3. Effective virus-neutralizing activities in antisera from the first wave of survivors of severe COVID-19. JCI Insight. 2021 02 22; 6(4).
    View in: PubMed
    Score: 0.008
  4. Association of D-dimer elevation with inflammation and organ dysfunction in ICU patients with COVID-19 in Wuhan, China: a retrospective observational study. Aging (Albany NY). 2021 02 11; 13(4):4794-4810.
    View in: PubMed
    Score: 0.008
  5. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021 01 16; 397(10270):220-232.
    View in: PubMed
    Score: 0.008
  6. DVT incidence and risk factors in critically ill patients with COVID-19. J Thromb Thrombolysis. 2021 Jan; 51(1):33-39.
    View in: PubMed
    Score: 0.008
  7. Derivation and validation of a prognostic model for predicting in-hospital mortality in patients admitted with COVID-19 in Wuhan, China: the PLANS (platelet lymphocyte age neutrophil sex) model. BMC Infect Dis. 2020 Dec 17; 20(1):959.
    View in: PubMed
    Score: 0.008
  8. The kinetics of humoral response and its relationship with the disease severity in COVID-19. Commun Biol. 2020 12 11; 3(1):780.
    View in: PubMed
    Score: 0.008
  9. Coagulation dysfunction in ICU patients with coronavirus disease 2019 in Wuhan, China: a retrospective observational study of 75 fatal cases. Aging (Albany NY). 2020 12 09; 13(2):1591-1607.
    View in: PubMed
    Score: 0.008
  10. The incidence, risk factors and prognosis of acute kidney injury in severe and critically ill patients with COVID-19 in mainland China: a retrospective study. BMC Pulm Med. 2020 Nov 09; 20(1):290.
    View in: PubMed
    Score: 0.008
  11. Clinical course and predictors of 60-day mortality in 239 critically ill patients with COVID-19: a multicenter retrospective study from Wuhan, China. Crit Care. 2020 07 06; 24(1):394.
    View in: PubMed
    Score: 0.008
  12. Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial. Trials. 2020 May 24; 21(1):422.
    View in: PubMed
    Score: 0.008
  13. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2020 05 16; 395(10236):1569-1578.
    View in: PubMed
    Score: 0.008
  14. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020 02 20; 382(8):727-733.
    View in: PubMed
    Score: 0.008
  15. [Characteristics of Organic Phosphorus Fractions in the Sediments of the Black Water Aggregation in Lake Taihu]. Huan Jing Ke Xue. 2016 Nov 08; 37(11):4194-4202.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.